• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    I-VASC Raises 1.8M Euros in Series A Funding

    Endotronix Shares Positive SIRONA 2 Heart Failure Trial Data

    FDA Clears Truvic's Prodigy Thrombectomy System

    Medical Device CEO Charged With Tax Evasion

    MPO's Most-Read Stories This Week—May 21
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Cirtec Medical

    Trademark Plastics Inc.

    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.

    Xact Wire EDM Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Cirtec Medical

    Trademark Plastics Inc.

    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.

    Xact Wire EDM Corp.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Theranos: Not Long for the Business World?

    ...

    Theranos: Not Long for the Business World?
    Elizabeth Holmes, the chief executive officer and founder of Theranos, at a Palo Alto, Calif. event in 2013. (DoD photo by Glenn Fawcett/Released)
    Related CONTENT
    • Private Equity Group to Buy Medline for Over $30B
    • Imec Developing Five Minute COVID Test
    • Abbott
    • Medical Devices and the Political Climate of 2018: An Update from the Swamp
    • Medtech M&A Off to a Strong Start in 2018
    Michael Barbella, Managing Editor05.03.18
    It won’t be long now.

    With a skeleton staff, dwindling finances, a sullied reputation, and a disgraced leader under criminal investigation, embattled blood testing firm Theranos Inc. seems veritably destined for a terrible, miserable, no good, very sad ending.

    In mid-April, The Wall Street Journal reported the company furloughed most of its remaining workforce in a desperate attempt to stave off bankruptcy, leaving roughly two dozen employees (at most) to run the business. The downsizing is the latest setback in a series of damning headlines, U.S. government probes, and failed pivots that have precipitated the firm’s self-implosion over the last few years.

    The most recent round of layoffs occurred in the wake of fraud allegations against Theranos CEO Elizabeth Holmes and former president Ramesh “Sunny” Balwani. A U.S. Securities and Exchange Commission (SEC) complaint filed on March 14 accuses the pair of misleading investors by raising more than $700 million through “exaggerated or false statements” about the company’s technology and financial performance. Holmes quickly settled with the SEC without admitting any wrongdoing, agreeing to pay a $500,000 penalty; surrender most of her Theranos stock; and accept a decade-long ban on corporate board service. Theranos’ independent directors released a brief statement when the settlement was announced, declaring, “The company is pleased to bring this matter to a close and looks forward to advancing its technology.”

    Balwani, contrarily, is fighting the SEC charges. He became company president in 2009 after guaranteeing a line of credit for the financially struggling Holmes, according to the SEC complaint.

    Theranos’ fairy tale-like existence began to unravel in October 2015 with a Journal expose that questioned the authenticity of the company’s proprietary technology, an iMedicine vision, of sorts, for blood testing. Its miniLab blood analyzer (the size of a desktop computer) purportedly could run hundreds of different diagnostic tests on just a few drops of blood, thereby eliminating the need for long needles and multiple vials. Holmes boasted that the technology would be “faster, cheaper, and more accurate” than alternatives, and claimed the U.S. Department of Defense had used the tests on Afghanistan battlefields. Neither assertion was true though, the SEC contends.

    The deception, however, extended beyond the corner office: The SEC charges that Theranos employees wrote flattering reports about the firm’s own products and affixed pharmaceutical company logos to them to make it appear as if the drugmakers endorsed Theranos’ technology.

    One of the most flagrant examples of Theranos’ deceit involved claims the blood analyzer could process more than 1,000 Current Procedural Terminology codes and that Theranos had developed a technological solution for an additional 300 codes. “But Theranos’ analyzers never performed comprehensive testing or processed 1,000 CPT codes in its clinical lab,” the SEC countered in its complaint. “In fact, as far as Holmes knew, or was reckless in not knowing, Theranos’ clinical lab used the TSPU [Theranos Sample Processing Unit] only to perform 12 of the tests offered to patients.”

    Since its exposure as a fraud, Theranos has voided nearly 1 million blood test results in Arizona and California, and shut two laboratories where its blood analyzers were producing unreliable data. Late last year, the company secured a $100 million loan from private equity firm Fortress Investment Group LLC but received only $65 million up front, the Journal reported.

    To access the rest of the funding, Theranos must meet certain product and operational milestones, including obtaining U.S. Food and Drug Administration approval for a Zika blood test. Such approval could prove difficult, however, due to unreliable test results.

    The layoffs announced last month should keep Theranos afloat through July, but Holmes is hoping to secure the company’s long-term future with additional investments. In an April 10 email detailed by the Journal, Holmes appealed to investors for additional funding, offering to sell a large stake of the firm at a favorable price. She may have trouble, though, finding financiers who are willing to forgive (and forget) her past sins so quickly.

    “If what she’s been charged with is true, she’s a criminal who should be in prison,” one tech investor told Vanity Fair in March. “I highly doubt Elizabeth Holmes set out to be a fraud—much in the same way that I don’t think Bernie Madoff’s business plan from day one was to run a Ponzi scheme. Does that even matter? All founders are faced with difficult choices, and the vast majority of them make the right call, erring on the side of transparency and honesty. To dismiss her wrongdoing is to discount all the founders who, knowing they had the wrong answer for an investor, made the hard choice to tell the truth, knowing it might be the final nail for their company.”

    Some venture capitalists blamed Theranos’ downfall partly on a business model that “encourages” companies to raise massive amounts of money without ever developing a product or proving market need. One investor even faulted the stockholders themselves.

    “It’s on her [Holmes], it’s on the company, it’s on the investors, and the board members who didn’t ask any of the right questions,” one Silicon Valley financier noted to Vanity Fair. “Or, evidently, any questions at all.”  
    Related Searches
    • 2015
    • ban
    • president
    • blood
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Private Equity Group to Buy Medline for Over $30B Private Equity Group to Buy Medline for Over $30B
    Imec Developing Five Minute COVID Test Imec Developing Five Minute COVID Test
    Abbott Abbott
    Medical Devices and the Political Climate of 2018: An Update from the Swamp Medical Devices and the Political Climate of 2018: An Update from the Swamp
    Medtech M&A Off to a Strong Start in 2018 Medtech M&A Off to a Strong Start in 2018
    LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System
    Software Validation: How It Should Be Done Software Validation: How It Should Be Done
    FDA FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices
    Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    Theranos’ Holmes and Former President Balwani Charged with Massive Fraud Theranos’ Holmes and Former President Balwani Charged with Massive Fraud
    AtriCure Names Board Chairman AtriCure Names Board Chairman
    FDA Expands Heart Valve Approval to Include Size for Newborn Patients FDA Expands Heart Valve Approval to Include Size for Newborn Patients
    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    Qosina Announces Scott Herskovitz as New President and Chief Executive Officer Qosina Announces Scott Herskovitz as New President and Chief Executive Officer

    Related Content

    • Private Equity Group to Buy Medline for Over $30B

      Private Equity Group to Buy Medline for Over $30B

      Medline will remain a privately held, family-led company.
      Sam Brusco, Associate Editor 06.07.21

    • Diagnostics
      Imec Developing Five Minute COVID Test

      Imec Developing Five Minute COVID Test

      Approach will use virus particles in exhaled breath to identify positive cases and confirm contagion risk.
      Imec 10.30.20

    • Abbott

      Abbott

      ...
      07.21.20


    • Medical Devices and the Political Climate of 2018: An Update from the Swamp

      Medical Devices and the Political Climate of 2018: An Update from the Swamp

      ...
      Jeffrey J. Kimbell and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 05.03.18

    • Medtech M&A Off to a Strong Start in 2018

      Medtech M&A Off to a Strong Start in 2018

      ...
      Mark Bonifacio, President, Bonifacio Consulting Services 05.03.18


      Trending
      • Quality Management Evolution: What to Expect in 2022
      • 5 Ways Plastics Revolutionized The Healthcare Industry | Medical Product Outsourcing
      • 7 Steps To Create Your Own Medical Device Marketing Plan | Medical Product Outsourcing
      • MPO's Most-Read Stories This Week—May 21 | Medical Product Outsourcing
      • Quality Management Evolution: What To Expect In 2022 | Medical Product Outsourcing
      Breaking News
      • I-VASC Raises 1.8M Euros in Series A Funding
      • Endotronix Shares Positive SIRONA 2 Heart Failure Trial Data
      • FDA Clears Truvic's Prodigy Thrombectomy System
      • RSIP Vision Develops New AI Tool for Prostate MRI Analysis
      • Medical Device CEO Charged With Tax Evasion
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Vitafoods Europe 2022 Attendance Returns to 2019 Level
      Beyond Raw Launches Concept X Pre-Workout Line
      Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort
      Coatings World

      Latest Breaking News From Coatings World

      PPG’s Diane Kappas Recognized as ‘Woman of Influence’ by Pittsburgh Business Times
      BEHR Launches COPPER FORCE Interior Paint
      A New Kind of Primer: Demand for Interior and Exterior Paint Experts Remains High, J.D. Power Finds
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      I-VASC Raises 1.8M Euros in Series A Funding
      Endotronix Shares Positive SIRONA 2 Heart Failure Trial Data
      FDA Clears Truvic's Prodigy Thrombectomy System
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Thermo Fisher, Qatar Genome Program Partner to Advance Precision Medicine
      CPC Launches AseptiQuik Genderless Connector
      Aptamer Group and PinotBio Extend Collaboration Agreement
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      L’Oréal USA Names Han Wen as Chief Digital & Marketing Officer
      NPD Group Reports on Rising E-commerce Sales in China for Prestige Beauty
      Noon Aesthetics Celebrates Ten Years with New Skincare Products
      Happi

      Latest Breaking News From Happi

      Gabriel Letizia Jr. Sentenced to 60 Months in Prison for Falsifying Sunscreen Test Results
      Coptis Appoints Marie Renee Thadal Vice President of Sales and Operations
      Han Wen Appointed L’Oréal’s New Chief Digital, Marketing Officer
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Zeller+Gmelin, Sun Chemical and Kornit Top This Week’s News
      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Avery Dennison announces Core Series Portfolio Tape Selector App
      HP Indigo reaches 2,000th active install milestone
      Brook + Whittle's new acquisition, SunDance goes to HP and more
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Ahlstrom-Munksjö Announces Reorganization of Decor Business Ownership
      Jones Names COO
      Ontex Conducts Pilot Program of Digital Incontinence Care Solution
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Tom Hedman Named Senior Principal Scientist at Spinal Simplicity
      ODT's Most Read Stories This Week—May 21
      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Graphene Flagship, Japan Display and LG Display Top This Week’s Stories
      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login